Regulus Therapeutics Reports Positive Phase 1b Topline Data and Oversubscribed $100 Million Private Placement of Equity
DENVER, Colo., Mar 12, 2024 (247marketnews.com)- Regulus Therapeutics Inc. (NASDAQ:RGLS) reported, this morning, positive topline results from the second cohort...